Companies Dice Therapeutics, Inc.
Dice Therapeutics CEO salary & total pay, FY2022: $5.8M
Dice Therapeutics (DICE) CEO salary, fiscal 2022: J. Kevin Judice was paid a salary of $540,000 and $5,773,577 in total compensation. Free brief. Every figure links to the company’s own filing.
Dice Therapeutics, Inc. no longer files a proxy statement; its last pay data is FY2022.
J. Kevin Judice's complete compensation dossier
A PDF and a CSV sent to your email: J. Kevin Judice's pay in every fiscal year Dice Therapeutics, Inc. reported it, line by line, with J. Kevin Judice's equity grants and Dice Therapeutics, Inc.'s disclosed peer group where the company discloses them. Every row is cited to its filing.
See an example →CEO pay, last three years
- $5,561,963FY2021
- $5,773,577FY2022
CEO total pay was $5,773,577 in fiscal 2022, up from $5,561,963 in fiscal 2021.
FY2022: salary $540,000 · bonus $0 · stock awards $0 · option awards $4,933,577
Executives and directors
Frequently asked questions
Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.
Full detail
Every table from the filing. Open any section.
Summary compensation table
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| J. Kevin Judice | $540,000 | $0 | $0 | $4,933,577 | $300,000 | $0 | $0 | $5,773,577 |
| Chief Executive Officer | ||||||||
| Timothy Lu | 450,000 | 0 | 0 | 2,022,088 | 250,000 | 0 | 0 | 2,722,088 |
| Chief Medical Officer | ||||||||
| Scott Robertson | 440,000 | 0 | 0 | 1,977,149 | 250,000 | 0 | 0 | 2,667,149 |
| Chief Business and Financial Officer | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
Three-year trend — total compensation per named executive
| Named executive officer | FY2022 total | FY2021 total | FY2020 total | Δ FY2021→2022 |
|---|---|---|---|---|
| J. Kevin Judice | $5,773,577 | $5,561,963 | — | ↑ +211,614 |
| Timothy Lu | 2,722,088 | 2,038,779 | — | ↑ +683,309 |
| Scott Robertson | 2,667,149 | 2,379,018 | — | ↑ +288,131 |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
Incentive-plan design — the Compensation Discussion & Analysis
The company's compensation program is designed to attract, retain, and motivate highly qualified executives by providing competitive base salaries and annual cash bonuses tied to the achievement of corporate performance objectives, including research and development milestones and operational priorities.
| CEO STI target (% of salary) | — |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | — |
| Clawback policy | true |
| Anti-hedging | true |
| Anti-pledging | false |
Equity grants and outstanding awards
Grants of plan-based awards — fiscal year 2022
| Executive | Award | Grant date | Threshold | Target | Granted | Maximum | Grant-date fair value |
|---|---|---|---|---|---|---|---|
| J. Kevin Judice | OPTION | 2022-04-14 | — | — | 384,900 | — | $4,933,577 |
| Timothy Lu | OPTION | 2022-04-14 | — | — | 157,756 | — | 2,022,088 |
| Scott Robertson | OPTION | 2022-04-14 | — | — | 154,250 | — | 1,977,149 |
Vehicle mix — grant-date fair value by award type
| Named executive officer | Time-vested (RSU) | Performance-vested (PSU) | Options / SARs | % performance-vested |
|---|---|---|---|---|
| J. Kevin Judice | $0 | $0 | $4,933,577 | 0.0% |
| Timothy Lu | 0 | 0 | 2,022,088 | 0.0% |
| Scott Robertson | 0 | 0 | 1,977,149 | 0.0% |
% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.
Outstanding equity awards at fiscal year-end 2022
| Executive | Award | Exercisable | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|---|
| J. Kevin Judice | Option | 20,464 | — | 17 | — |
| J. Kevin Judice | RSU | — | 167,102 | — | 5,213,582 |
| J. Kevin Judice | Option | 123,469 | 156,293 | 17 | — |
| J. Kevin Judice | Option | 88,206 | 296,694 | 19.64 | — |
| Scott Robertson | RSU | — | 416 | — | 12,979 |
| Scott Robertson | RSU | — | 12,058 | — | 376,210 |
| Scott Robertson | RSU | — | 21,163 | — | 660,286 |
| Scott Robertson | RSU | — | 7,255 | — | 226,356 |
| Scott Robertson | Option | 61,327 | 60,493 | 17 | — |
| Scott Robertson | Option | 35,348 | 118,902 | 19.64 | — |
| Scott Robertson | Option | 7,191 | — | 17 | — |
| Timothy Lu | RSU | — | 41,509 | — | 1,295,081 |
| Timothy Lu | RSU | — | 32,637 | — | 1,018,274 |
| Timothy Lu | Option | 18,260 | 13,044 | 17 | — |
| Timothy Lu | Option | 26,652 | 42,108 | 17 | — |
| Timothy Lu | Option | 36,152 | 121,604 | 19.64 | — |
Director compensation
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| Mittie Doyle, M.DIndependent · Nominating and Corporate Governance · Research and Development | $31,875 | $0 | $520,636 | — | — | $552,511 |
| Lisa BowersIndependent · Compensation | 31,875 | 0 | 520,636 | — | — | 552,511 |
| Richard Scheller, Ph.DIndependent · Board Chair · Research and Development (Chair) | 66,875 | 0 | 305,001 | — | — | 371,876 |
| Jim ScopaIndependent · Audit · Compensation (Chair) | 57,500 | 0 | 207,400 | — | — | 264,900 |
| Sharon TetlowIndependent · Audit (Chair) · Nominating and Corporate Governance | 57,500 | 0 | 207,400 | — | — | 264,900 |
| Jake Simson, Ph.DIndependent · Audit · Compensation · Research and Development | 24,045 | 0 | 207,400 | — | — | 231,445 |
| Shaan C. Gandhi, M.D., D.PhilIndependent | 3,438 | 0 | 0 | — | — | 3,438 |
| Stephen Zachary, Ph.DIndependent · Departed during FY | 0 | 0 | 0 | — | — | — |
Board fee structure and ownership guideline
| Annual cash retainer | $35,000 |
|---|---|
| Annual equity retainer | — |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | 15,000 / 15,000 / 15,000 |
| Stock ownership guideline | — |
Total cost of the board
| Component | FY2022 |
|---|---|
| Cash retainers and fees | $273,108 |
| Equity awards (grant-date value) | $0 |
| All other compensation | $0 |
| Total cost of the board | $273,108 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
Peer group, and who names Dice Therapeutics as a peer
Companies that benchmark against DICE
No companies currently name DICE as a compensation peer in their most recent disclosure.
This is the complete answer, not a partial one — the list is never padded.
Chief executive pay against the peer group
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company’s own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | Dice Therapeutics, Inc. | 2022 | J. Kevin Judice | $540,000 | $0 | $4,933,577 | $300,000 | $5,773,577 |
Each peer’s compensation is from its most recently filed proxy; fiscal years differ by company. Each peer’s figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
Say-on-pay history and pay ratio
| Meeting year | Meeting date | For | Against | Abstain | Support | Outcome |
|---|---|---|---|---|---|---|
| 2023 | 2023-06-07 | — | — | — | — | — |
| 2022 | 2022-06-07 | — | — | — | — | — |
Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year’s compensation.
Say-on-pay — history, company’s computation
| Meeting year | Meeting date | Approval — company’s computation |
|---|---|---|
| 2023 | 2023-06-07 | —a |
| 2022 | 2022-06-07 | —b |
a. Voting standard not stated in the filing.
b. Voting standard not stated in the filing.
Approval percentages are the company’s own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.
Insider trades since the proxy
Every insider equity transaction reported on Form 4 after the 2022 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.
| Insider | Role | Transaction date | Code | Shares | Price | Value | Security | Source |
|---|---|---|---|---|---|---|---|---|
| Jim Scopa | Director | 2023-05-01 | A | 6,923 | $0 | $0 | Common | Form 4 ↗ |
| Jim Scopa | Director | 2023-05-01 | D | 6,923 | 0 | 0 | Common | Form 4 ↗ |
| Lu Timothy | CMO | 2023-05-03 | D | 10,000 | 37 | 365,398 | Common | Form 4 ↗ |
| J. Kevin Judice | Director | 2023-05-03 | D | 13,698 | 37 | 499,977 | Common | Form 4 ↗ |
| Scott Robertson | CFO & CBO | 2023-05-03 | D | 18,750 | 37 | 685,350 | Common | Form 4 ↗ |
| Richard H. Scheller | Director | 2023-05-05 | D | 84,097 | 39 | 3,238,205 | Common | Form 4 ↗ |
| John R. Jacobsen | CSO | 2023-06-01 | D | 4,443 | 31 | 138,799 | Common | Form 4 ↗ |
| John R. Jacobsen | CSO | 2023-06-01 | D | 14,307 | 30 | 433,645 | Common | Form 4 ↗ |
| Northpond Ventures GP, LLC | Greater-than-10% holder | 2023-06-22 | D | 523,503 | 47 | 24,342,890 | Common | Form 4 ↗ |
| Northpond Ventures GP, LLC | Greater-than-10% holder | 2023-06-22 | D | 1,969,368 | 47 | 91,575,612 | Common | Form 4 ↗ |
| Jim Scopa | Director | 2023-07-11 | D | 300 | 0 | 0 | Common | Form 4 ↗ |
| Jim Scopa | Director | 2023-07-18 | D | 2,200 | 0 | 0 | Common | Form 4 ↗ |
| Jim Scopa | Director | 2023-08-02 | D | 2,200 | 0 | 0 | Common | Form 4 ↗ |
| Jim Scopa | Director | 2023-08-02 | D | 220 | 0 | 0 | Common | Form 4 ↗ |
| RA CAPITAL MANAGEMENT, L.P. | — | 2023-08-09 | D | 21,250 | — | — | Derivative, Class A Common | Form 4 ↗ |
| RA CAPITAL MANAGEMENT, L.P. | — | 2023-08-09 | D | 786,407 | — | — | Common | Form 4 ↗ |
| RA CAPITAL MANAGEMENT, L.P. | — | 2023-08-09 | D | 7,070,205 | — | — | Common | Form 4 ↗ |
| Jim Scopa | Director | 2023-08-09 | D | 15,199 | — | — | Common | Form 4 ↗ |
| Sharon Tetlow | Director | 2023-08-09 | D | 21,250 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Sharon Tetlow | Director | 2023-08-09 | D | 13,800 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Sharon Tetlow | Director | 2023-08-09 | D | 8,261 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Sharon Tetlow | Director | 2023-08-09 | D | 12,096 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Sharon Tetlow | Director | 2023-08-09 | D | 49,841 | — | — | Common | Form 4 ↗ |
| John R. Jacobsen | CSO | 2023-08-09 | D | 154,250 | — | — | Derivative, Class A Common | Form 4 ↗ |
| John R. Jacobsen | CSO | 2023-08-09 | D | 46,324 | — | — | Derivative, Class A Common | Form 4 ↗ |
| John R. Jacobsen | CSO | 2023-08-09 | D | 11,064 | — | — | Derivative, Class A Common | Form 4 ↗ |
| John R. Jacobsen | CSO | 2023-08-09 | D | 7,579 | — | — | Derivative, Class A Common | Form 4 ↗ |
| John R. Jacobsen | CSO | 2023-08-09 | D | 14,341 | — | — | Derivative, Class A Common | Form 4 ↗ |
| John R. Jacobsen | CSO | 2023-08-09 | D | 4,408 | — | — | Derivative, Class A Common | Form 4 ↗ |
| John R. Jacobsen | CSO | 2023-08-09 | D | 1,344 | — | — | Derivative, Class A Common | Form 4 ↗ |
| John R. Jacobsen | CSO | 2023-08-09 | D | 4,229 | — | — | Derivative, Class A Common | Form 4 ↗ |
| John R. Jacobsen | CSO | 2023-08-09 | D | 1,278 | — | — | Derivative, Class A Common | Form 4 ↗ |
| John R. Jacobsen | CSO | 2023-08-09 | D | 922 | — | — | Derivative, Class A Common | Form 4 ↗ |
| John R. Jacobsen | CSO | 2023-08-09 | D | 4,367 | — | — | Derivative, Class A Common | Form 4 ↗ |
| John R. Jacobsen | CSO | 2023-08-09 | D | 147,497 | — | — | Common | Form 4 ↗ |
| Richard H. Scheller | Director | 2023-08-09 | D | 31,250 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Richard H. Scheller | Director | 2023-08-09 | D | 22,600 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Richard H. Scheller | Director | 2023-08-09 | D | 8,261 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Richard H. Scheller | Director | 2023-08-09 | D | 9,138 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Richard H. Scheller | Director | 2023-08-09 | D | 4,357 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Richard H. Scheller | Director | 2023-08-09 | D | 8,427 | — | — | Common | Form 4 ↗ |
| Jake Simson | Director | 2023-08-09 | D | 21,250 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Jim Scopa | Director | 2023-08-09 | D | 21,250 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Jim Scopa | Director | 2023-08-09 | D | 13,800 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Jim Scopa | Director | 2023-08-09 | D | 8,261 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Jim Scopa | Director | 2023-08-09 | D | 12,096 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Jim Scopa | Director | 2023-08-09 | D | 25,722 | — | — | Common | Form 4 ↗ |
| Scott Robertson | CFO & CBO | 2023-08-09 | D | 18,750 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Scott Robertson | CFO & CBO | 2023-08-09 | D | 112,500 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Scott Robertson | CFO & CBO | 2023-08-09 | D | 154,250 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Scott Robertson | CFO & CBO | 2023-08-09 | D | 56,920 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Scott Robertson | CFO & CBO | 2023-08-09 | D | 15,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Scott Robertson | CFO & CBO | 2023-08-09 | D | 16,595 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Scott Robertson | CFO & CBO | 2023-08-09 | D | 9,095 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Scott Robertson | CFO & CBO | 2023-08-09 | D | 2,688 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Scott Robertson | CFO & CBO | 2023-08-09 | D | 20,751 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Scott Robertson | CFO & CBO | 2023-08-09 | D | 771 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Scott Robertson | CFO & CBO | 2023-08-09 | D | 7,191 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Scott Robertson | CFO & CBO | 2023-08-09 | D | 198,000 | — | — | Common | Form 4 ↗ |
| Lisa Bowers | Director | 2023-08-09 | D | 42,500 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Lu Timothy | CMO | 2023-08-09 | D | 15,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Lu Timothy | CMO | 2023-08-09 | D | 90,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Lu Timothy | CMO | 2023-08-09 | D | 157,756 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Lu Timothy | CMO | 2023-08-09 | D | 43,167 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Lu Timothy | CMO | 2023-08-09 | D | 25,593 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Lu Timothy | CMO | 2023-08-09 | D | 31,304 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Lu Timothy | CMO | 2023-08-09 | D | 152,285 | — | — | Common | Form 4 ↗ |
| Mittie Doyle | Director | 2023-08-09 | D | 42,500 | — | — | Derivative, Class A Common | Form 4 ↗ |
| J. Kevin Judice | Director | 2023-08-09 | D | 50,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| J. Kevin Judice | Director | 2023-08-09 | D | 300,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| J. Kevin Judice | Director | 2023-08-09 | D | 384,900 | — | — | Derivative, Class A Common | Form 4 ↗ |
| J. Kevin Judice | Director | 2023-08-09 | D | 132,074 | — | — | Derivative, Class A Common | Form 4 ↗ |
| J. Kevin Judice | Director | 2023-08-09 | D | 131,027 | — | — | Derivative, Class A Common | Form 4 ↗ |
| J. Kevin Judice | Director | 2023-08-09 | D | 16,661 | — | — | Derivative, Class A Common | Form 4 ↗ |
| J. Kevin Judice | Director | 2023-08-09 | D | 20,464 | — | — | Derivative, Class A Common | Form 4 ↗ |
| J. Kevin Judice | Director | 2023-08-09 | D | 799,685 | — | — | Common | Form 4 ↗ |
| John R. Jacobsen | CSO | 2023-08-09 | D | 15,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| John R. Jacobsen | CSO | 2023-08-09 | D | 90,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.
Sources (98 citations)
Each figure is listed with the filing it comes from, where it appears in that filing, and the value as printed. Any figure can be independently confirmed against the source.
- Section 01, J. Kevin Judice. DEF 14A, filed 2023-04-26. Section “Executive Compensation” · page 23. As printed: 5,773,577. View filing ↗
- Section 01, Timothy Lu. DEF 14A, filed 2023-04-26. Section “Executive Compensation” · page 23. As printed: 2,722,088. View filing ↗
- Section 01, Scott Robertson. DEF 14A, filed 2023-04-26. Section “Executive Compensation” · page 23. As printed: 2,667,149. View filing ↗
- Section 03, J. Kevin Judice OPTION. DEF 14A, filed 2023-04-26. Section “Executive Compensation” · grants of plan-based awards table. View filing ↗
- Section 03, Timothy Lu OPTION. DEF 14A, filed 2023-04-26. Section “Executive Compensation” · grants of plan-based awards table. View filing ↗
- Section 03, Scott Robertson OPTION. DEF 14A, filed 2023-04-26. Section “Executive Compensation” · grants of plan-based awards table. View filing ↗
- Section 08, Mittie Doyle, M.D. DEF 14A, filed 2023-04-26. Section “Director Compensation”. As printed: 552,511. View filing ↗
- Section 08, Lisa Bowers. DEF 14A, filed 2023-04-26. Section “Director Compensation”. As printed: 552,511. View filing ↗
- Section 08, Richard Scheller, Ph.D. DEF 14A, filed 2023-04-26. Section “Director Compensation”. As printed: 371,876. View filing ↗
- Section 08, Jim Scopa. DEF 14A, filed 2023-04-26. Section “Director Compensation”. As printed: 264,900. View filing ↗
- Section 08, Sharon Tetlow. DEF 14A, filed 2023-04-26. Section “Director Compensation”. As printed: 264,900. View filing ↗
- Section 08, Jake Simson, Ph.D. DEF 14A, filed 2023-04-26. Section “Director Compensation”. As printed: 231,445. View filing ↗
- Section 08, Shaan C. Gandhi, M.D., D.Phil. DEF 14A, filed 2023-04-26. Section “Director Compensation”. As printed: 3,438. View filing ↗
- Section 08, Stephen Zachary, Ph.D. DEF 14A, filed 2023-04-26. Section “Director Compensation”. As printed: —. View filing ↗
- Section 02, Jim Scopa 2023-05-01. Form 4, filed 2023-05-02. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Jim Scopa 2023-05-01. Form 4, filed 2023-05-02. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Lu Timothy 2023-05-03. Form 4, filed 2023-05-05. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, J. Kevin Judice 2023-05-03. Form 4, filed 2023-05-05. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Scott Robertson 2023-05-03. Form 4, filed 2023-05-05. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Richard H. Scheller 2023-05-05. Form 4, filed 2023-05-09. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, John R. Jacobsen 2023-06-01. Form 4, filed 2023-06-02. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, John R. Jacobsen 2023-06-01. Form 4, filed 2023-06-02. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Northpond Ventures GP, LLC 2023-06-22. Form 4, filed 2023-06-23. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Northpond Ventures GP, LLC 2023-06-22. Form 4, filed 2023-06-23. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Jim Scopa 2023-07-11. Form 4, filed 2023-07-13. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Jim Scopa 2023-07-18. Form 4, filed 2023-07-19. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Jim Scopa 2023-08-02. Form 4, filed 2023-08-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Jim Scopa 2023-08-02. Form 4, filed 2023-08-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, RA CAPITAL MANAGEMENT, L.P. 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, RA CAPITAL MANAGEMENT, L.P. 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, RA CAPITAL MANAGEMENT, L.P. 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Jim Scopa 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Sharon Tetlow 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Sharon Tetlow 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Sharon Tetlow 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Sharon Tetlow 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Sharon Tetlow 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, John R. Jacobsen 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, John R. Jacobsen 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, John R. Jacobsen 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, John R. Jacobsen 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, John R. Jacobsen 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, John R. Jacobsen 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, John R. Jacobsen 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, John R. Jacobsen 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, John R. Jacobsen 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, John R. Jacobsen 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, John R. Jacobsen 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, John R. Jacobsen 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Richard H. Scheller 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Richard H. Scheller 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Richard H. Scheller 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Richard H. Scheller 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Richard H. Scheller 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Richard H. Scheller 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Jake Simson 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Jim Scopa 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Jim Scopa 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Jim Scopa 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Jim Scopa 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Jim Scopa 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Scott Robertson 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Scott Robertson 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Scott Robertson 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Scott Robertson 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Scott Robertson 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Scott Robertson 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Scott Robertson 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Scott Robertson 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Scott Robertson 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Scott Robertson 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Scott Robertson 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Scott Robertson 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Lisa Bowers 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Lu Timothy 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Lu Timothy 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Lu Timothy 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Lu Timothy 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Lu Timothy 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Lu Timothy 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Lu Timothy 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mittie Doyle 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, J. Kevin Judice 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, J. Kevin Judice 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, J. Kevin Judice 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, J. Kevin Judice 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, J. Kevin Judice 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, J. Kevin Judice 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, J. Kevin Judice 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, J. Kevin Judice 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, John R. Jacobsen 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, John R. Jacobsen 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 06, 2023 vote. Form 8-K, filed 2023-06-07. Item 5.07 · say-on-pay result. As reported: —. View filing ↗
- Section 06, 2022 vote. Form 8-K, filed 2022-06-08. Item 5.07 · say-on-pay result. As reported: —. View filing ↗
- Section 01 trend, Δ column (computed). Computed. Δ = current-FY total − prior-FY total per named officer.
- Section 03b vehicle mix (computed). Computed. RSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).
- Section 09b board cost (computed). Computed. Cash 273,108 + equity 0 + all other 0 = 273,108, summed across the director compensation table rows.
- Dice Therapeutics, Inc. (subject), Section 10b CEO total. DEF 14A, filed 2023-04-26. CEO total compensation as printed in Dice Therapeutics, Inc.'s own proxy. As printed: 5,773,577. View filing ↗